CH Biotech R&D Co., Ltd. (6534.TW)
TWD 76.0
(0.0%)
TWD 76.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.51 Billion | 1.43 Billion | 1.01 Billion | 702.18 Million | 840.68 Million |
| Cost of Revenue | 254.73 Million | 299.52 Million | 170.55 Million | 112.18 Million | 143.55 Million |
| Gross Profit | 1.26 Billion | 1.13 Billion | 847.94 Million | 590 Million | 697.12 Million |
| Operating Expenses | 694.23 Million | 623.53 Million | 488.67 Million | 444.93 Million | 439.28 Million |
| Selling, General and Administrative Expenses | 389 Million | 351.12 Million | 267.19 Million | 251.59 Million | 276.98 Million |
| Research and Development Expenses | 305.23 Million | 272.41 Million | 221.48 Million | 193.33 Million | 162.3 Million |
| Other Expenses | 4.45 Million | 3.58 Million | 25.72 Million | 28.01 Million | - |
| Cost and Expenses | 948.96 Million | 923.06 Million | 659.23 Million | 557.11 Million | 582.84 Million |
| Operating Income | 594.67 Million | 582.04 Million | 373.43 Million | 150.09 Million | 257.83 Million |
| Interest Expense | 16.81 Million | 16.81 Million | 13.89 Million | 22.73 Million | 21.65 Million |
| Income Tax Expense | 115.64 Million | 100.37 Million | 68.15 Million | 27.23 Million | 51.79 Million |
| Earnings before Tax | 578.93 Million | 565.79 Million | 359.65 Million | 127.39 Million | 242.25 Million |
| Net Income | 463.29 Million | 465.42 Million | 291.49 Million | 100.16 Million | 190.46 Million |
| Earnings Per Share Basic | 4.76 | 4.79 | 3.00 | 1.03 | 1.97 |
| Earnings Per Share Diluted | 4.73 | 4.72 | 2.97 | 1.03 | 1.94 |
| Weighted Average Shares Outstanding | 97.27 Million | 97.08 Million | 97.08 Million | 97.08 Million | 97.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 97.86 Million | 98.62 Million | 98.09 Million | 97.66 Million | 98.02 Million |
| Gross Margin | 0.83 | 0.79 | 0.83 | 0.84 | 0.83 |
| EBIT Margin | 0.50 | 0.50 | 0.46 | 0.35 | 0.42 |
| Profit Margin | 0.31 | 0.32 | 0.29 | 0.14 | 0.23 |
| EBITDA | 761.55 Million | 722.29 Million | 470.2 Million | 248.32 Million | 352.05 Million |
| Earnings Before Tax Margin | 0.39 | 0.41 | 0.37 | 0.21 | 0.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 400.72 Million | 824.8 Million | 143.73 Million | 1.51 Billion | 110.93 Million | 459.3 Million |
| Cost of Revenue | 65.98 Million | 111.14 Million | 34.02 Million | 254.73 Million | 23.8 Million | 75.05 Million |
| Gross Profit | 334.74 Million | 713.66 Million | 109.7 Million | 1.26 Billion | 87.12 Million | 384.25 Million |
| Operating Expenses | 190.37 Million | 217.43 Million | 165.09 Million | 694.23 Million | 168.81 Million | 165.2 Million |
| Selling, General and Administrative Expenses | 102.59 Million | 126.22 Million | 98.33 Million | - | 77.24 Million | 90.7 Million |
| Research and Development Expenses | 87.78 Million | 91.21 Million | 66.75 Million | - | 91.56 Million | 74.5 Million |
| Other Expenses | 728 Thousand | 1.2 Million | 947 Thousand | 4.45 Million | 2.13 Million | 1.11 Million |
| Cost and Expenses | 256.36 Million | 328.57 Million | 199.11 Million | 948.96 Million | 192.61 Million | 240.26 Million |
| Operating Income | 162.17 Million | 526.5 Million | -74.69 Million | 594.67 Million | -53.59 Million | 238.23 Million |
| Interest Expense | 3.99 Million | 3.5 Million | 3.97 Million | 16.81 Million | 4.07 Million | 4.5 Million |
| Income Tax Expense | 30.08 Million | 103.92 Million | -1.89 Million | 115.64 Million | -14.14 Million | 43.71 Million |
| Earnings before Tax | 159.87 Million | 522.99 Million | -77.91 Million | 578.93 Million | -57.7 Million | 233.72 Million |
| Net Income | 130.14 Million | 419.07 Million | -76.01 Million | 463.29 Million | -43.55 Million | 190.01 Million |
| Earnings Per Share Basic | 1.27 | 4.08 | -0.76 | - | -0.45 | 1.96 |
| Earnings Per Share Diluted | 1.26 | 4.06 | -0.76 | - | -0.45 | 1.92 |
| Weighted Average Shares Outstanding | 102.47 Million | 102.8 Million | 100.03 Million | 97.27 Million | 96.78 Million | 96.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 103.28 Million | 103.34 Million | 100.6 Million | 97.86 Million | 96.78 Million | 98.96 Million |
| Gross Margin | 0.84 | 0.87 | 0.76 | 0.83 | 0.79 | 0.84 |
| EBIT Margin | 0.52 | 0.69 | -0.21 | - | -0.11 | 0.61 |
| Profit Margin | 0.32 | 0.51 | -0.53 | 0.31 | -0.39 | 0.41 |
| EBITDA | 208.69 Million | 572.33 Million | -30.22 Million | - | -12.02 Million | 278.55 Million |
| Earnings Before Tax Margin | 0.40 | 0.64 | -0.52 | 0.39 | -0.48 | 0.52 |
DXI
RCGH
1341
5267
APR-UN
APEI